Propanc Biopharma, Inc. Common Stock Capital Reinvestment Ratio

Latest as of December 2024: 0.00x

Propanc Biopharma, Inc. Common Stock capital reinvestment ratio. Propanc Biopharma, Inc. Common Stock (PPCB) has a Capital Reinvestment Ratio of 0.00x as of December 2024, meaning it reinvests 0% of its operating cash flow ($18.73K) in capital expenditures ($5.00). Check how aggressively does Propanc Biopharma, Inc. Common Stock reinvest cash to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.00x

Capex / Operating Cash Flow

Operating Cash Flow

$18.73K

USD

Capital Expenditures

$5.00

USD

Data as of

Dec 2024

Most recent filing

Propanc Biopharma, Inc. Common Stock Capital Reinvestment Ratio by Year (None–None)

Propanc Biopharma, Inc. Common Stock capital reinvestment ratio by year from None to None. For the full cash flow conversion analysis, see PPCB operating cash flow.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow